Zenith and Newsoara Biopharma Announce Expanded Licensing and Investment
CALGARY, Alberta, Nov. 15, 2021 (GLOBE NEWSWIRE) — Zenith Capital Corp. (“Zenith” or the “Company”) announced today that Zenith Epigenetics
CALGARY, Alberta, Nov. 15, 2021 (GLOBE NEWSWIRE) — Zenith Capital Corp. (“Zenith” or the “Company”) announced today that Zenith Epigenetics
SHANGHAI, China and REDWOOD CITY, Calif., Nov. 15, 2021 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd. (“Junshi Biosciences”, HKEX:
DURHAM, N.C., Nov. 15, 2021 (GLOBE NEWSWIRE) — CoImmune, Inc., a clinical stage immuno-oncology company working to redefine cancer treatment
TORONTO, Nov. 15, 2021 (GLOBE NEWSWIRE) — Digihost Technology Inc. (“Digihost” or the “Company”) (TSXV: DGHI; Nasdaq: DGHI), an innovative
FDA Feedback Supports Planned Emergency Use Authorization (EUA) Submission for ADG20 for Prevention of COVID-19; Interim Clinical Data Package from
Sportradar’s proven fraud detection services to help protect the integrity of global handball competition BASEL, Switzerland & ST GALLEN, Switzerland,
InsulCheck DOSE by Innovation Zed DUBLIN, Nov. 15, 2021 (GLOBE NEWSWIRE) — Innovation Zed, developer of novel diabetes management technologies
Copyright © 2024 Singapore News Gazette. All Rights Reserved.